Vis enkel innførsel

dc.contributor.authorGrimolizzi, Franco
dc.contributor.authorArranz, Lorena
dc.date.accessioned2019-02-05T10:11:24Z
dc.date.available2019-02-05T10:11:24Z
dc.date.issued2018-06-28
dc.description.abstractSuccinate is an essential intermediate of the tricarboxylic acid cycle that exerts pleiotropic roles beyond metabolism in both physiological and pathological conditions. Recent evidence obtained in mouse models shows its essential role regulating blood cell function through various mechanisms that include pseudohypoxia responses by hypoxiainducible factor-1α activation, post-translational modifications like succinylation, and communication mediated by succinate receptor 1. Hence, succinate links metabolism to processes like gene expression and intercellular communication. Interestingly, succinate plays key dual roles during inflammatory responses, leading to net inflammation or anti-inflammation depending on factors like the cellular context. Here, we further discuss current suggestions of the possible contribution of succinate to blood stem cell function and blood formation. Further study will be required in the future to better understand succinate biology in blood cells. This promising field may open new avenues to modulate inflammatory responses and to preserve blood cell homeostasis in the clinical setting.en_US
dc.description.sponsorshipNorthern Norway Regional Health Authority: ? the University Hospital of Northern Norway (UNN): ? UiT The Arctic University of Norway: (2014/5668) The Norwegian Cancer Society: (6765150), The Northern Norway Regional Health Authority: (HNF1338-17), The Aakre-Stiftelsen Foundation: (2016/9050)en_US
dc.descriptionSource at: <a href=http://doi.org/10.3324/haematol.2018.196097>http://doi.org/10.3324/haematol.2018.196097</a>. Licensed <a href=http://creativecommons.org/licenses/by-nc-nd/4.0/> CC BY-NC-ND 4.0. </a>en_US
dc.identifier.citationGrimolizzi, F. & Arranz, L. (2018). Multiple faces of succinate beyond metabolism in blood. <i>Haematologica, 103</i>(10), 1586-1592en_US
dc.identifier.cristinIDFRIDAID 1622607
dc.identifier.doi10.3324/haematol.2018.196097
dc.identifier.issn0390-6078
dc.identifier.issn1592-8721
dc.identifier.urihttps://hdl.handle.net/10037/14610
dc.language.isoengen_US
dc.publisherFerrata Storti Foundationen_US
dc.relation.journalHaematologica
dc.relation.projectIDinfo:eu-repo/grantAgreement/RCN/EMBLNODE/187615/Norway/Norsk senter for molekylærmedisin (NCMM) - Centre for Molecular Medicine Norway - Nordic EMBL Partnership/NCMM/en_US
dc.relation.projectIDinfo:eu-repo/grantAgreement/RCN/FRIMEDBIO/144182/Norway/Stem Cell Metabolic Dysfunction in Myeloid Leukaemia and its Therapeutic Targeting//en_US
dc.rights.accessRightsopenAccessen_US
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Hematology: 775en_US
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775en_US
dc.titleMultiple faces of succinate beyond metabolism in blooden_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel